phase readout
saveNCT04555551: MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
ACTIVE_NOT_RECRUITINGupdated 15d ago
community read0 votes
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Multiple Myeloma
view source ↗
comments(0)
5-min edit window · permanent after that